Pulmonary effect of amiodarone in patients with heart failure

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 514-517

  Singh, Steven N ^a,b   Fisher, Susan G ^a,b   Deedwania, Prakash C ^a,b   Rohatgi, Prashant ^a,b   Singh, Bramah N ^a,b   Fletcher, Ross D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; FEMALE; HEART FAILURE; HUMAN; HYPERSENSITIVITY; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SURVIVAL;

AGED; AMIODARONE; CARBON MONOXIDE; HEART FAILURE, CONGESTIVE; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY FIBROSIS; VASODILATOR AGENTS;

EID: 0030802870     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00157-5     Document Type: Article

References (16)

1. Kudenchuk PJ, Pierson DJ, Greene HL, Graham EL, Sears GK, Trobaugh GB. Prospective evaluation of amiodarone pulmonary toxicity. Chest. 86:1984;541-548.
2. Fraire AE, Guntupalli KK, Greenberg D, Cartwright J, Chasen MH. Amiodarone pulmonary toxicity a multidisciplinary review of current studies . South Med J. 86:1993;67-76.
3. Wilson JS, Podrid PJ. Side effects of amiodarone. Am Heart J. 121:1991;158-171.
4. Neal Kay G, Epstein AE, Kirklin TK, Diethelm AG, Graybar G, Plumb VJ. Fatal postoperative amiodarone pulmonary toxicity. Am J Cardiol. 62:1988;490-492.
5. Greenspon AJ, Kidwell GA, Hurley W, Mannion J. Amiodarone-related post-operative adult respiratory distress syndrome. Circulation. 84:(Suppl III):1991;III-407-III-415.
6. Nalos PC, Kass RM, Gang ES, Fishbein MC, Mandel WJ, Peter T. Life-threatening post-operative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations. J Thorac Cardiovasc Surg. 93:1987;904-912.
7. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 333:1995;77-82.
8. Dean PJ, Groshart KD, Porterfield JG, Iansmith DH, Golden EB. Amiodarone-associated pulmonary toxicity a clinical and pathologic study of eleven cases . Am J Clin Pathol. 87:1987;7-13.
9. Akoun GM, Gauthier-Rahman S, Milleron BJ, Perrot JY, Mayand CM. Amiodarone-induced hypersensitivity pneumonitis evidence of an immunological cell-mediated mechanism . Chest. 85:1984;133-135.
10. Magro SA, Lawrence CE, Wheeler SH, Krafchek J, Huang-ta L, Wyndham C. Amiodarone pulmonary toxicity prospective evaluation of serial pulmonary function tests . J Am Coll Cardiol. 12:1988;781-788.
11. Doval HC, Nul DR, Vancelli HO, et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet. 344:1994;493-498.
12. Burkart F, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias Basel Antiarrhythmic Study of Infarct Survival (BASIS) . J Am Coll Cardiol. 16:1990;1171-1178.
13. Ceremuzynski L, Kleczar E, Krzeminsk-Pakula M, et al. Effect of amiodarone on mortality after myocardial infarction a double-blind, placebo-controlled, pilot study . J Am Coll Cardiol. 20:1992;1056-1062.
14. Navarro-Lopez F, Cosin J, Marrugat J, Guindo J, Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after myocardial infarction. Am J Cardiol. 72:1993;1243-1248.
15. The CASCADE study - randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am J Cardiol. 72:1993;280-287.
16. Chelimsky-Fallick C, Middlekauff HR, Stevenson WG, et al. Amiodarone does not compromise subsequent heart transplantation. J Am Coll Cardiol. 20:1992;1556-1561.